Page last updated: 2024-10-21

1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and Retinal Degeneration

1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine has been researched along with Retinal Degeneration in 2 studies

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine: A dopaminergic neurotoxic compound which produces irreversible clinical, chemical, and pathological alterations that mimic those found in Parkinson disease.
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine : A tetrahydropyridine that is 1,2,3,6-tetrahydropyridine substituted by a methyl group at position 1 and a phenyl group at position 4.

Retinal Degeneration: A retrogressive pathological change in the retina, focal or generalized, caused by genetic defects, inflammation, trauma, vascular disease, or aging. Degeneration affecting predominantly the macula lutea of the retina is MACULAR DEGENERATION. (Newell, Ophthalmology: Principles and Concepts, 7th ed, p304)

Research Excerpts

ExcerptRelevanceReference
"Studies on Parkinson's disease patients and dopamine-depleted animals indicate that dopaminergic neurons in the retina degenerate due to the genetic and environmental factors that cause dopaminergic neuron loss in the substantia nigra."1.37Minor retinal degeneration in Parkinson's disease. ( Huang, YM; Yin, ZQ, 2011)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Pinelli, R1
Biagioni, F1
Bertelli, M1
Busceti, CL1
Scaffidi, E1
Ryskalin, L1
Fornai, F1
Huang, YM1
Yin, ZQ1

Other Studies

2 other studies available for 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and Retinal Degeneration

ArticleYear
Retinal Degeneration Following Chronic Administration of the Parkinsonism-Inducing Neurotoxin MPTP.
    Archives italiennes de biologie, 2021, Jun-30, Volume: 159, Issue:2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Dopamine; Mice; Neurotoxins; Parkinsonian Dis

2021
Minor retinal degeneration in Parkinson's disease.
    Medical hypotheses, 2011, Volume: 76, Issue:2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Dopamine; Hallucinations; Haplorhini; Humans;

2011